MedTech Innnovator Military Pitch Strategic Interest Areas 2020


MedTech Innovator is sourcing opportunities in partnership with US Army for a military pitch event to be held March 25 in Baltimore, MD. The following list highlights technologies identified as specifically of interest by the US Military for this event. If you know a company that matches any of these interest areas, then please encourage them to apply. Though you may submit anything that you think is pertinent, startups will be reviewed first against these priorities.

Submissions should ideally be for technologies that have not been previously submitted to the US Army. Apply to MedTech Innovator at Please be sure to check the military box within the Special Application Categories in Section 1.


  • Direct retinal displays
  • Volumetric holography – military medical use
  • Neuro haptics & haptics technology
  • Immersive holodeck & immersion teaching tools
  • Robotic medical patient surrogates
  • Tools to improve learning effectiveness, memory & retention, cognitive performance
  • Empathy generators – live, virtual, augmented reality
  • Nanosensors & communication
  • 3D nanoprinting & novel inks
  • Human-machine interface – medical focus
  • Wearable technology to detect physiological or host biomarkers as predictive and prognostic indicators of infection-induced sepsis
  • Safe and efficacious interventions to be utilized at the point of injury for eradication of bacterial pathogens from contaminated wounds and inhibition/disruption of biofilms formed by MDR pathogens. Examples of target wound-associated bacteria are: Acinetobacter baumannii, Staphylococcus aureus, E. coli, and Klebsiella pneumoniae
  • A broad spectrum anti-viral that provides Warfighters durable immunity and protection from naturally occurring endemic infectious diseases

Artificial intelligence for real-time medical command awareness in multi-domain operations

  • Use of AI tools and techniques to automate medical documentation (EHR and other clinical information)
  • Use of AI in clinical decision support to enable remote provision of care and for improved patient safety/monitoring

Technology Objectives: The Clinical and Rehabilitative Medicine Research Program has identified a need for regenerative medicine prototype development efforts and manufacturing technologies. Current Good manufacturing practice (cGMP) quality is a requirement by the FDA and European Medicines Agency to provide patients with clinical-grade products that are safe and have defined quality characteristics. However, standardization and robust manufacturing techniques are lacking in regenerative medicine, which will continue to impede progress in advancing regenerative medicine based technologies and treatments toward the clinic. This is likely due to many factors which need to be developed and advanced, including 1) Processing technologies for Quality Management of acellular matrices or Stem Cell (SC)-derived cell based therapies. 2) Manufactured Universal Acellular Matrix 2) Innovative Manufacturing Process for SC-Derived Cell Based Therapies. Based on this, the major objective of this effort is to develop solutions for quality management of prototypes and processes for cell, tissue, or organ bioengineering technologies that will overcome current challenges and enable successful cGMP manufacturing and clinical translation of regenerative medicine based therapies.

Technologies of interest include the following:

    • Processing technologies for quality assurance of acellular matrices or SC-derived cell based therapies (assurance, control, or quality testing)
    • Manufactured universal acellular matrix
    • Innovative manufacturing process for stem cell (SC)-derived cell based therapies
  • Wearable, on-demand device for the management of symptoms associated with PTSD that is efficacious in a military or veteran population
  • Guidelines on the implementation of human-automation teaming that optimizes human performance and increases operational effectiveness
  • Injury risk model for the brain and spine when the whole body is subjected to potentially hazardous acceleration/deceleration loads from military relevant exposures
  • Brain injury risk model, test methodology, and assessment tool that can output probability of brain injury risk resulting from single and repetitive blast exposures
  • Medically-based performance requirements that can provide behind helmet blunt trauma survivability and brain injury risk curves for helmets exposed to current and emerging ballistic threats
  • Whole body blast injury criteria to evaluate the next generation bomb suit and body armor blast personal protection equipment
  • An efficient and effective method for personalized training to build and enhance cognitive/brain health, performance and psychological health
  • Individual training modalities and thermal models that reduce cold-weather injuries and improve cold weather performance
  • Models that quantify impacts of glymphatic/lymphatic clearance in the brain on short-term impacts on the restorative effects of sleep
  • Limitation of burn conversion and burn treatments
  • Non-compressible hemorrhage
  • Supplemental and therapeutic oxygen